Detalhe da pesquisa
1.
Utilization of donor-derived Cell-Free DNA in pediatric kidney transplant recipients: A single center study.
Pediatr Transplant
; 28(1): e14582, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37550268
2.
Graft Cryopreservation Does Not Impact Overall Survival after Allogeneic Hematopoietic Cell Transplantation Using Post-Transplantation Cyclophosphamide for Graft-versus-Host Disease Prophylaxis.
Biol Blood Marrow Transplant
; 26(7): 1312-1317, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32283185
3.
Tandem Autologous-Autologous versus Autologous-Allogeneic Hematopoietic Stem Cell Transplant for Patients with Multiple Myeloma: Long-Term Follow-Up Results from the Blood and Marrow Transplant Clinical Trials Network 0102 Trial.
Biol Blood Marrow Transplant
; 26(4): 798-804, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31756536
4.
Hematopoietic Cell Transplantation with Cryopreserved Grafts for Severe Aplastic Anemia.
Biol Blood Marrow Transplant
; 26(7): e161-e166, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32389803
5.
Effect of Conditioning Regimen Dose Reduction in Obese Patients Undergoing Autologous Hematopoietic Cell Transplantation.
Biol Blood Marrow Transplant
; 25(3): 480-487, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30423481
6.
Autologous/Allogeneic Hematopoietic Cell Transplantation versus Tandem Autologous Transplantation for Multiple Myeloma: Comparison of Long-Term Postrelapse Survival.
Biol Blood Marrow Transplant
; 24(3): 478-485, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29079457
7.
Outcomes of Measurable Residual Disease in Pediatric Acute Myeloid Leukemia before and after Hematopoietic Stem Cell Transplant: Validation of Difference from Normal Flow Cytometry with Chimerism Studies and Wilms Tumor 1 Gene Expression.
Biol Blood Marrow Transplant
; 24(10): 2040-2046, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29933069
8.
Umbilical Cord Blood Transplantation in Children with Acute Leukemia: Impact of Conditioning on Transplantation Outcomes.
Biol Blood Marrow Transplant
; 23(10): 1714-1721, 2017 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-28684372
9.
Hispanics have the lowest stem cell transplant utilization rate for autologous hematopoietic cell transplantation for multiple myeloma in the United States: A CIBMTR report.
Cancer
; 123(16): 3141-3149, 2017 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28472539
10.
Patient-Reported Outcomes and Socioeconomic Status as Predictors of Clinical Outcomes after Hematopoietic Stem Cell Transplantation: A Study from the Blood and Marrow Transplant Clinical Trials Network 0902 Trial.
Biol Blood Marrow Transplant
; 22(12): 2256-2263, 2016 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27565521
11.
Patient-reported physical functioning predicts the success of hematopoietic cell transplantation (BMT CTN 0902).
Cancer
; 122(1): 91-8, 2016 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26439325
12.
Results of a prospective multicentre myeloablative double-unit cord blood transplantation trial in adult patients with acute leukaemia and myelodysplasia.
Br J Haematol
; 168(3): 405-12, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25272241
13.
Validated graft-specific biomarkers identify patients at risk for chronic graft-versus-host disease and death.
J Clin Invest
; 133(15)2023 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37526081
14.
Early Experience Using Donor-derived Cell-free DNA for Surveillance of Rejection Following Simultaneous Pancreas and Kidney Transplantation.
Transplant Direct
; 8(5): e1321, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35415217
15.
Mass-Fix better predicts for PFS and OS than standard methods among multiple myeloma patients participating on the STAMINA trial (BMT CTN 0702 /07LT).
Blood Cancer J
; 12(2): 27, 2022 02 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35145071
16.
Myeloablative versus Reduced-Intensity Conditioning for Hematopoietic Cell Transplantation in Acute Myelogenous Leukemia and Myelodysplastic Syndromes-Long-Term Follow-Up of the BMT CTN 0901 Clinical Trial.
Transplant Cell Ther
; 27(6): 483.e1-483.e6, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33775615
17.
Impact of Conditioning Intensity and Genomics on Relapse After Allogeneic Transplantation for Patients With Myelodysplastic Syndrome.
JCO Precis Oncol
; 52021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34036237
18.
Impact of Conditioning Intensity of Allogeneic Transplantation for Acute Myeloid Leukemia With Genomic Evidence of Residual Disease.
J Clin Oncol
; 38(12): 1273-1283, 2020 04 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-31860405
19.
Kinetics of immune cell reconstitution predict survival in allogeneic bone marrow and G-CSF-mobilized stem cell transplantation.
Blood Adv
; 3(15): 2250-2263, 2019 08 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-31345792
20.
Three prophylaxis regimens (tacrolimus, mycophenolate mofetil, and cyclophosphamide; tacrolimus, methotrexate, and bortezomib; or tacrolimus, methotrexate, and maraviroc) versus tacrolimus and methotrexate for prevention of graft-versus-host disease with haemopoietic cell transplantation with reduced-intensity conditioning: a randomised phase 2 trial with a non-randomised contemporaneous control group (BMT CTN 1203).
Lancet Haematol
; 6(3): e132-e143, 2019 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-30824040